P&G Health PAT Plunges 21% to Rs 46 Crore in March Quarter

P&G Health's profit after tax dropped 21% to Rs 46 crore for the third quarter ending March 2024 due to operational revenue decline. The company aims to recoup losses and strengthen its distribution model.

Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024.

The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago.

Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing.

''The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory,'' P&G Health India Managing Director Milind Thatte said.

''However, we have seen sales recover in the months of March and April,'' he added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)